drugset / Trial / NCT04201574
Phase 1/2a Safety and Efficacy of ALY688 Ophthalmic Solution in Subjects With Dry Eye Disease
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Clinical Trial Evaluating the Safety and Tolerability of ALY688 in Subjects with Dry Eye Disease
Timeline
- Start
- 2019-12-16
- Primary completion
- 2020-09-15
- Completion
- 2020-09-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ALY688 | Unknown | 0.1 % | Other |
| Subject | ALY688 | Unknown | 0.4 % | Other |